logo

SKYE

Skye Bioscience·NASDAQ
--
--(--)
--
--(--)
3.78 / 10
Netural

Fund-flow analysis shows a good score of 7.56/10, with positive block, small-cap, and extra-large inflows offsetting medium and large negative trends. This robust capital movement supports the idea of underlying interest. Analyst sentiment is overwhelmingly bullish (100% Strong Buy from one analyst), but the historical win rate is 0%, limiting conviction. Overall, the combination of strong fund inflows and bullish ratings is tempered by poor historical performance data, keeping the signal at a neutral level.

FundamentalSentiment(3.78)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-09-30
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of SKYE?
  • SKYE holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.78/10 (Netural).